Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × berzosertib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 1 Leiomyosarcoma 1

Interventions

Doxorubicin 22 Gemcitabine 15 Trabectedin 11 Ifosfamide 11 Radiotherapy 10 Docetaxel 10 Dacarbazine 8 pazopanib 6 Temozolomide 4 Specimen Handling 4 Nivolumab 4 Biopsy 4 Sunitinib 3 Sorafenib 3 Filgrastim 3 pembrolizumab 2 pegfilgrastim 2 liposomal doxorubicin 2 eribulin 2 cixutumumab 2 cemiplimab 2 brostallicin 2 belinostat 2 avelumab 2 X-Rays 2 Surgical Procedures, Operative 2 Radiotherapy, Conformal 2 Radiation Dose Hypofractionation 2 Radiation 2 PTC596 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03718091 2023-07-07

M6620 (VX-970) in Selected Solid Tumors

Massachusetts General Hospital

Phase 2 Completed

30 enrolled 15 charts

Leiomyosarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡